Toxicological Evaluation of a Probiotic-Based Delivery System for P8 Protein as an Anti-Colorectal Cancer Drug

References

• WeitzJ, KochM, DebusJ, et al. Colorectal cancer. Lancet. 2005;365(9454):153–165. doi:10.1016/S0140-6736(05)17706-X15639298
   PubMed Web of Science ®Google Scholar
• ZhangL, RenX, AltE, et al. Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis. Nature. 2010;464(7291):1058–1061. doi:10.1038/nature0887120348907
   PubMed Web of Science ®Google Scholar
• WidakowichC, de CastroG Jr, de AzambujaE, et al. Review: side effects of approved molecular targeted therapies in solid cancers. Oncologist. 2007;12(12):1443–1455. doi:10.1634/theoncologist.12-12-144318165622
   PubMed Web of Science ®Google Scholar
• WidakowichC, de CastroGJ, de AzambujaE, et al. Review: side effects of approved molecular targeted therapies in solid cancers. Oncologist. 2010;12(12):1443–1455.
   Web of Science ®Google Scholar
• EjtahedHS, Mohtadi-NiaJ, Homayouni-RadA, et al. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition. 2012;28(5):539–543. doi:10.1016/j.nut.2011.08.01322129852
   PubMed Web of Science ®Google Scholar
• PerezM, AstoE, HuedoP, et al. Derived postbiotics of a multi-strain probiotic formula clinically validated for the treatment of irritable bowel syndrome. FASEB J. 2020;34(S1):1.
   Google Scholar
• TomasikP, TomasikP. Probiotics, non-dairy prebiotics and postbiotics in nutrition. Appl Sci. 2020;10(4):1470. doi:10.3390/app10041470
   Google Scholar
• HarishK, VargheseT. Probiotics in humans–evidence based review. Calicut Med J. 2006;4(4):e3.
   PubMed Web of Science ®Google Scholar
• NarayanSS, JalgaonkarS, ShahaniS, et al. Probiotics: current trends in the treatment of diarrhoea. Hong Kong Med J. 2010;16(3):213–218.20519758
   PubMedGoogle Scholar
• MoeinianM, FarnazGhasemi-NiriS, MozaffariS, et al. Synergistic effect of probiotics, butyrate and l-Carnitine in treatment of IBD. J Med Hypotheses Ideas. 2013;7(2):50–53. doi:10.1016/j.jmhi.2013.02.003
   Google Scholar
• KelesidisT, PothoulakisC. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap Adv Gastroenterol. 2012;5(2):111–125. doi:10.1177/1756283X11428502
   PubMed Web of Science ®Google Scholar
• JonkersD, PendersJ, MascleeA, et al. Probiotics in the management of inflammatory bowel disease. Drugs. 2012;72(6):803–823. doi:10.2165/11632710-000000000-0000022512365
   PubMed Web of Science ®Google Scholar
• OakSJ, JhaR. The effects of probiotics in lactose intolerance: a systematic review. Crit Rev Food Sci Nutr. 2018;59(11):1675–1683. doi:10.1080/10408398.2018.142597729425071
   PubMed Web of Science ®Google Scholar
• MarioU, GiuliaM, FrancescoB, et al. Potential role of probiotics on colorectal cancer prevention. BMC Surg. 2012;12(Suppl 1):S1–S35.
   Google Scholar
• RanjbarS, SeyednejadSA, AzimiH, et al. Emerging roles of probiotics in prevention and treatment of breast cancer: a comprehensive review of their therapeutic potential. Nutr Cancer. 2019;71(1):1–12. doi:10.1080/01635581.2018.155722130686054
   PubMed Web of Science ®Google Scholar
• BelizárioEJ, FaintuchJ. Microbiome and gut dysbiosis. Exp Suppl. 2018;109:459–476.30535609
   PubMedGoogle Scholar
• BackhedF, FraserCM, RingelY, et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe. 2012;12(5):611–622. doi:10.1016/j.chom.2012.10.01223159051
   PubMed Web of Science ®Google Scholar
• SteidlerL, VandenbrouckeK. Genetically modified Lactococcus lactis: novel tools for drug delivery. Int J Dairy Technol. 2006;59(2):140–146. doi:10.1111/j.1471-0307.2006.00255.x
   Web of Science ®Google Scholar
• QuigleyEM. Gut microbiota and the role of probiotics in therapy. Curr Opin Pharmacol. 2011;11(6):593–603. doi:10.1016/j.coph.2011.09.01021996283
   PubMed Web of Science ®Google Scholar
• ZhongL, ZhangX, CovasaM. Emerging roles of lactic acid bacteria in protection against colorectal cancer. World J Gastroenterol. 2014;20(24):7878–7886. doi:10.3748/wjg.v20.i24.787824976724
   PubMed Web of Science ®Google Scholar
• Sadeghi-AliabadiH, MohammadiF, FazeliH, et al. Effects of Lactobacillus plantarum A7 with probiotic potential on colon cancer and normal cells proliferation in comparison with a commercial strain. Iran J Basic Med Sci. 2014;17:815–819.25729553
   PubMed Web of Science ®Google Scholar
• AnBC, RyuY, HongS, et al. Probiotics as potential therapeutics for colorectal cancer. Am J Biomed Sci Res. 2020;9(2). DOI:10.34297/AJBSR.2020.09.001362
   Google Scholar
• HörmannspergerG, von SchilldeMA, HallerD. Lactocepin as a protective microbial structure in the context of IBD. Gut Microbes. 2013;4(2):152–157. doi:10.4161/gmic.2344423333860
   PubMed Web of Science ®Google Scholar
• von SchilldeMA, HörmannspergerG, WeiherM, et al. Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell Host Microbe. 2012;11(4):387–396. doi:10.1016/j.chom.2012.02.00622520466
   PubMed Web of Science ®Google Scholar
• FlambardB, JuillardV. The autoproteolysis of Lactococcus lactis lactocepin III affects its specificity towards β-casein. Appl Environ Microbiol. 2000;66(12):5134–5140. doi:10.1128/AEM.66.12.5134-5140.200011097880
   PubMed Web of Science ®Google Scholar
• AnBC, RyuY, ChoiO, et al. Genetic engineering of a probiotic-based drug delivery system for colorectal cancer therapy. Cancer Rep Rev. 2020;4:2–3.
   Google Scholar
• AnBC, RyuY, YoonYS, et al. Colorectal cancer therapy using a Pediococcus pentosaceus SL4 drug delivery system secreting lactic acid bacteria derived protein P8. Mol Cells. 2019;30:755–762.
   Google Scholar
• AnBC, HongS, ParkHJ, et al. Anti-colorectal cancer effects of probiotic-derived P8 protein. Genes. 2019;10(8):624. doi:10.3390/genes10080624
   Web of Science ®Google Scholar
• KimB-K, YoonY-S, RyuR, et al. Probiotic-derived P8 protein induce apoptosis via regulation of RNF152 in colorectal cancer cells. Am J Cancer Res. 2021;11(3):746–759.33791151
   PubMed Web of Science ®Google Scholar
• GiezenTJ, Mantel-TeeuwisseAK, StrausSM, et al. Safety-related regulatory actions for biological approved in the United States and the European Union. JAMA. 2008;300:1887–1896.18940975
   PubMed Web of Science ®Google Scholar
• AmouzadehHR, VargasHM. Safety pharmacology assessment of biopharmaceuticals. In: VogelHG, editor. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Berlin: Springer; 2013:555–560.
   Google Scholar
• ChungY, RyuY, AnBC, et al. A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota. Microbiome. 2021;9(1):122. doi:10.1186/s40168-021-01071-434039418
   PubMed Web of Science ®Google Scholar
• JabirSM, SalehMY, SulaimanMJ, et al. Green synthesis of silver nanoparticles using annona muricata extract as an inducer of apoptosis in cancer cells and inhibitor for NLRP3 inflammasome via enhanced autophagy. Nanomaterials. 2021;11(2):384. doi:10.3390/nano1102038433546151
   PubMed Web of Science ®Google Scholar
• KavranMJ, LeahyJD. Coupling antibody to cyanogen bromide-activated sepharose. Method Enzymol. 2014;541:27–34.
   PubMed Web of Science ®Google Scholar
• MoserCA, HageSD. Immunoaffinity chromatography: an introduction to applications and recent developments. Bioanalysis. 2010;2(4):769–790. doi:10.4155/bio.10.3120640220
   PubMed Web of Science ®Google Scholar
• OECD. OECD principles of good laboratory practice; 1997. ENV/MC/CHEM(98)17.
   Google Scholar
• SmithD, TrenneryP, FarninghamD, et al. The selection of marmoset monkeys (Callithrix jacchus) in pharmaceutical toxicology. Lab Anim. 2001;35(2):117–130. doi:10.1258/002367701191144411315160
   PubMed Web of Science ®Google Scholar
• WilliamsTN. Probiotics. Am J Health Syst Pharm. 2010;67(6):449–458. doi:10.2146/ajhp09016820208051
   PubMed Web of Science ®Google Scholar
• KligerB, CohrssenA. Probiotics. Am Fam Physician. 2008;78(9):1073–1078.19007054
   PubMed Web of Science ®Google Scholar
• SenokAC, IsmaeelAY, BottaetGA. Probiotics: facts and myths. Clin Microbiol Infect. 2005;11(12):956–958. doi:10.1111/j.1469-0691.2005.01228.x
   Web of Science ®Google Scholar
• MimuraT, RizzelloF, HelwigU, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut. 2004;53(1):108–114. doi:10.1136/gut.53.1.10814684584
   PubMed Web of Science ®Google Scholar
• BibiloniR, FedorakNR, TannockWG, et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol. 2005;100(7):1539–1546. doi:10.1111/j.1572-0241.2005.41794.x15984978
   PubMed Web of Science ®Google Scholar
• KorteS, EverittJ. Chapter 27 - The use of the marmoset in toxicity testing and nonclinical safety assessment studies. In: The Common Marmoset in Captivity and Biomedical Research. Academic Press. 2019:493–513.
   Google Scholar
• HantonG, SobryC, DaguèsN, et al. Cardiovascular toxicity of minoxidil in the marmoset. Toxicol Lett. 2008;180(3):157–165. doi:10.1016/j.toxlet.2008.05.01818582543
   PubMed Web of Science ®Google Scholar
• TuckerMJ. A survey of the pathology of marmosets (Callithrix jacchus) under experiment. Lab Anim. 1984;18(4):351–358. doi:10.1258/0023677847808653976439947
   PubMed Web of Science ®Google Scholar
• KaspareitJ, Friderichs-GromollS, BuseE, et al. Background pathology of the common marmoset (Callithrix jacchus) in toxicological studies. Exp Toxicol Pathol. 2006;57(5–6):405–410. doi:10.1016/j.etp.2006.02.01316616834
   PubMedGoogle Scholar
• DavidMJ, DickJE Jr HubbardGB. Spontaneous pathology of the common marmoset (Callithrix jacchus) and tamarins (Saguinus oedipus, Saguinus mystax). J Med Primatol. 2009;38(5):347–359. doi:10.1111/j.1600-0684.2009.00362.x19522731
   PubMed Web of Science ®Google Scholar
• AliIH, JabirMS, Al-ShmganiHS, et al. Pathological and immunological study on infection with Escherichia coli in ale balb/c mice. In Journal of Physics: Conference Series ( Vol. 1003, No. 1). IOP Publishing; 2018:012009.
   Google Scholar
• KareemSH, NajiAM, TaqiZJ, et al. Polyvinylpyrrolidone loaded-MnZnFe2O4 magnetic nanocomposites induce apoptosis in cancer cells through mitochondrial damage and P53 pathway. J Inorg Organomet Polym Mater. 2020;30(12):5009–5023. doi:10.1007/s10904-020-01651-1
   Web of Science ®Google Scholar
• SmitherJS, NelsonM, EastaughL, et al. Experimental respiratory Marburg virus haemorrhagic fever infection in the common marmoset (Callithrix jacchus). Int J Exp Pathol. 2013;94(2):156–168. doi:10.1111/iep.1201823441639
   PubMed Web of Science ®Google Scholar
• CollinsMG, RogersNM, JesudasonS, et al. Spontaneous glomerular mesangial lesions in common marmoset monkeys (Callithrix jacchus): a benign non-progressive glomerulopathy. J Med Primatol. 2014;43(6):477–487. doi:10.1111/jmp.1213424980800
   PubMed Web of Science ®Google Scholar